Use of opioid formulations in needle-less drug delivery devices

US8987290B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8987290-B2
Application numberUS-43938607-A
CountryUS
Kind codeB2
Filing dateAug 29, 2007
Priority dateAug 29, 2006
Publication dateMar 24, 2015
Grant dateMar 24, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention concerns a needle-less drug delivery device being suitable for delivering drugs through a skin surface into a human or animal body comprising a pharmaceutical composition with at least one analgesic agent preferably being an opioid. The present invention also relates to the use of at least one analgesic agent, preferably being at least one opioid in a needle-less drug delivery device being suitable for injecting medication through a skin surface into the human or animal body. Further, the invention is concerned with a method of treating breakthrough pain by injecting at least one analgesic agent preferably being an opioid into the human or animal body using a needle-less drug delivery device.

First claim

Opening claim text (preview).

The invention claimed is: 1. A needleless drug delivery device suitable for injecting a pharmaceutical composition through a skin surface into a human or animal being, the needleless drug delivery device comprising: a container comprising two chambers separating a first pharmaceutical composition in one chamber from a second pharmaceutical composition in the other chamber; a means for generating a force capable of pushing the first pharmaceutical composition and not the second p…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8987290B2 cover?
The present invention concerns a needle-less drug delivery device being suitable for delivering drugs through a skin surface into a human or animal body comprising a pharmaceutical composition with at least one analgesic agent preferably being an opioid. The present invention also relates to the use of at least one analgesic agent, preferably being at least one opioid in a needle-less drug deli…
Who is the assignee on this patent?
Woodward Jo, Purdue Pharma Lp
What technology area does this patent fall under?
Primary CPC classification A61M5/30. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).